Publicador de continguts

LIVERAIM

A biomarker-based platform for early diagnosis of chronic liver disease to enable personalised therapy

Durada
01/03/2024 - 28/02/2029
Coordinador
Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer
Finançadors
Innovative Health Initiative Joint Undertaking (IHI JU), European Union’s Horizon Europe research and innovation programme, EFPIA, COCIR, MedTech Europe, Vaccines Europe and EuropaBio.

Innovative Health Initiative-funded project LIVERAIM aims to create and validate a biomarker-based screening platform to enable early detection of liver disease in asymptomatic individuals, allowing for personalised and effective therapeutic interventions to halt or reverse disease progression.

It brings together the top academic researchers in the field of liver disease, industry partners from both the biomarker and pharmaceutical industries, patient associations, leading health economists, public health experts and AI tool creators to form the LIVERAIM consortium.

Total Funding

24.800.000€

 

Our Team

Equipo ISGlobal

Veure més

Altres projectes

Veure projectes passats

COMBACTE

Combatent la Resistència Bacteriana a Europa

GAMA

Development of Novel Gastrointestinal Biomarkers for Use in HIV Incidence Determination in a Sub-Saharan African Setting

COMBACTE-CARE

Combatting Bacterial Resistance in Europe - Carbapenem Resistance

MAMAH

Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women

PreFIT

Predicting the Future: Incipient Tuberculosis

ANTICOV

Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19

Stool4TB

Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV

TB-RECONNECT

Reconnecting Transmission to Global Tuberculosis Control by Mapping Pathogen Transmission Events to Host Infection Status

SToolNIH

Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring

END-VOC

ENDing COVID-19 Variants Of concern through Cohort studies (END-VOC)

TwinAir

Digital Twins Enabled Indoor Air Quality Management for Healthy Living

ENDÈMIC

Community knowledge generation through scientific culture, urban ecology and art

EpiGen

Building Scalable Pathogen Genomic Epidemiology in Ethiopia

Hepatitis C Free Baleares

Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.

FLAVOBAC

Nuevas moléculas de oro coordinadas con flavonoides contra bacterias patógenas multirresistentes prioritarias

INTE-AFRICA

Integrating and decentralizing diabetes and hypertension services in Africa